---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-131263"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2024-11-27T23:59:59+00:00"
generated_at: "2026-05-29T13:28:33.873126+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Agenus secures $22M mortgage and announces realignment: 60% cost cut, FY25 cash burn ~$100M

## Summary
- $22M non-amortizing mortgage backed by Berkeley CMC facility and Vacaville land; net proceeds $20M after costs and reserve.
- Interest 12% Year 1, 13% Year 2, paid 50% cash and 50% common stock; 153,003 shares issued as first month interest and fees.
- Strategic Operational Realignment: 60% reduction in external expenditures; CMC transitioned to fee-for-service business.
- FY 2025 cash burn projected at ~$100M, pending finalization of additional strategic transactions.
- Focus on botensilimab/balstilimab (BOT/BAL) in MSS colorectal cancer for late-stage development and registration pathways.

## SEC filing metadata
- accession: 0000950170-24-131263
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2024-11-27T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017024131263/0000950170-24-131263-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017024131263/agen-20241126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-131263
- JSON: https://secwatch.observer/filing/0000950170-24-131263.json
- Plain text: https://secwatch.observer/filing/0000950170-24-131263.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.